Biopreservation Market Size Worth $15.12 Billion By 2030 | CAGR: 28.7%

The global biopreservation market size is expected to reach USD 15.12 billion by 2030, according to a new study by Polaris Market Research. The report “Biopreservation Market Share, Size, Trends, Industry Analysis Report, By Product (Equipment, Media, LIMS); By Application (Regenerative Medicine, Bio-banking, Drug Discovery); By Cell Providers Volume; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides an analysis of future market growth.

Growing R&D spending on medication development will help businesses expand. The sector will grow more quickly as there are more biobanks to hold the biological materials needed in various forms of medical research. The industry will continue to increase as a result of government measures to fund stem cell therapies for the treatment of diseases.

The development of room temperature storage techniques and strict regulations for the manufacture of biopreservation products, however, may impede the expansion of the industry in the near future.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/biopreservation-market/request-for-sample

The global market for biopreservation will expand as a result of rising healthcare costs. This is due to the fact that most countries' development budgets spend a sizable portion of their budgets on healthcare. According to World Bank data, public healthcare spending is anticipated to increase significantly over the next years. This large healthcare spending is likely to be a major driver for gene banks, hospitals, and biobanks, the main end users of the biopreservation market.

The COVID-19 pandemic has pushed the creation of novel biologics and vaccine techniques. The need for biopreservation will rise as a result of rising Covid-19 cases, which are projected to expand the potential for the creation and preservation of biologics.

Biopreservation Market Report Highlights

• The equipment segment dominated the market in 2021. The equipment category had the largest revenue share in 2021 because of the expanding demand for bio-banking to store stem cells, DNA, plasma, and tissue culture.
• Based on the cell provider, the tumor cells segment accounted for the largest revenue share in 2021. This can be an increase in activities like cancer therapy development in terms of diagnosis, research, and treatment.
• The use of animal-assisted reproduction technology, growing acceptance of sperm and egg banking, and growing knowledge of stem cell preservation are all contributing to the expansion of the bio-banking segment market.
• Over the forecast period, North America is anticipated to dominate and have the fastest growth. The emergence of contemporary biopreservation technology, the ethical use of biological samples required by the government, and the increasing demand for the detection of chronic illness causes are all factors in the development of this market.
• Major players operating in the industry include Azenta US, Inc., BioLife Solutions, Biomatrica, Inc., LabVantage Solutions, Inc., MVE Biological Solutions, PrincetonCryo, Stirling Ultracold, Taylor-Wharton, Thermo Fisher Scientific, Inc., X-Therma Inc., Worthington Industries, Inc. (US).

Polaris Market Research has segmented the Biopreservation Market report based on Product, Application, cell providers volume, and region:

Biopreservation, Product Outlook (Revenue - USD Billion, 2018 - 2030)

• Equipment
  • Freezers
  • Refrigerators
  • Consumables
    • Vials
    • Straws
    • Microtiter Plates
    • Bags
    • Liquid Nitrogen
• Media
  • Pre-formulated
  • Home-brew
• Laboratory Information Management System (LIMS)

Biopreservation, Application Outlook (Revenue - USD Billion, 2018 - 2030)

• Regenerative Medicine
  • Cell Therapy
  • Gene Therapy
  • Others
• Bio-banking
  • Human Eggs
  • Human Sperms
  • Veterinary IVF
• Drug Discovery

Biopreservation, Cell Providers Volume Outlook (Revenue - USD Billion, 2018 - 2030)

• CD34+
• CD19+
• MSC
• iPSC
• hESC
• Tumor Cells
• Others

Biopreservation, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

• North America
  • U.S
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa